ProCE Banner Activity

CME

Considering Rare Causes of Acute Abdominal Pain: A Diagnostic Dilemma

Text Module
Choose your diagnostic approach and get immediate feedback in these patient cases.

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: March 31, 2020

Expiration: March 30, 2021

No longer available for credit.

Share

Faculty

Herbert L. Bonkovsky

Herbert L. Bonkovsky, MD

Professor of Medicine and Molecular Medicine and Translational Science
Section on Gastroenterology & Hepatology
Wake Forest University School of Medicine
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Alnylam Pharmaceuticals

Target Audience

This program is primarily intended for gastroenterologists, emergency medicine specialists, and primary care practitioners and other clinicians who may see patients with abdominal symptoms related to porphyria.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Recognize the most common neurovisceral signs and symptoms of porphyria and how these can be overlooked or confused with other conditions
  • Identify the recommended laboratory tests that can help establish a diagnosis of porphyria
  • Describe the role of genetic testing that can pinpoint the type of porphyria

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty Disclosure

Primary Author

Herbert L. Bonkovsky, MD

Professor of Medicine and Molecular Medicine and Translational Science
Section on Gastroenterology & Hepatology
Wake Forest University School of Medicine
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina

Herbert L. Bonkovsky, MD, has disclosed that he received consulting fees from Recordat i Rare Chemicals and funds for research support from Alnylam, Gilead Sciences, and Mitsubishi Tanabe.

Staff Disclosure

Staff

Wendy Gloffke, PhD, ACCP

Editorial Contributor

Wendy Gloffke, PhD, has no relevant conflicts of interest to report.

Anne Roc, PhD

Director, Scientific Services

Anne Roc, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.

Instructions for Credit

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve the competence of learners in considering rare causes of acute abdominal pain and to perform appropriate diagnostic tests in a timely manner to establish the correct diagnosis.